Wells Fargo & Company MN Buys 1,210 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Wells Fargo & Company MN boosted its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 0.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 253,182 shares of the company’s stock after buying an additional 1,210 shares during the quarter. Wells Fargo & Company MN owned 0.68% of Crescent Capital BDC worth $4,866,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Montag A & Associates Inc. purchased a new position in shares of Crescent Capital BDC during the 4th quarter worth about $35,000. C M Bidwell & Associates Ltd. purchased a new position in shares of Crescent Capital BDC during the fourth quarter valued at approximately $39,000. Oppenheimer & Co. Inc. purchased a new position in shares of Crescent Capital BDC during the fourth quarter valued at approximately $261,000. Ieq Capital LLC grew its stake in shares of Crescent Capital BDC by 2.6% during the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock valued at $437,000 after buying an additional 584 shares during the last quarter. Finally, LPL Financial LLC raised its holdings in shares of Crescent Capital BDC by 10.0% in the fourth quarter. LPL Financial LLC now owns 24,437 shares of the company’s stock worth $470,000 after buying an additional 2,230 shares during the period. Institutional investors own 49.46% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CCAP shares. Keefe, Bruyette & Woods dropped their price objective on Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating for the company in a report on Tuesday, April 8th. Wells Fargo & Company lowered their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $18.90.

Crescent Capital BDC Trading Up 2.1 %

CCAP opened at $15.48 on Monday. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The stock’s fifty day moving average is $17.22 and its two-hundred day moving average is $18.41. The company has a market capitalization of $573.76 million, a P/E ratio of 7.78 and a beta of 0.56. Crescent Capital BDC, Inc. has a 52 week low of $13.54 and a 52 week high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The firm had revenue of $46.40 million for the quarter, compared to analysts’ expectations of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. Analysts forecast that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio (DPR) is 84.42%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.